The U.S. health care system is in a state of flux, and changes currently under way seem capable of exerting sizable effects on medical innovation. This volume explores how the rapid transition to managed care might affect the rate and direction of medical innovation. The experience with technological change in medicine in other nations whose health care systems have "single-payer" characteristics is thoroughly examined. Technology and Health Care in an Era of Limits examines how financing and care delivery strategies affect the decisions made by hospital administrators and physicians to adopt medical technologies. It also considers the patient's stake in the changing health care economy and the need for a stronger independent contribution of patients to the choice of technology used in their care. Finally, the volume explores the impact of changes in the demand for medical technology in pharmaceutical, medical device, and surgical procedure innovation.
Annetine C. Gelijns, Editor; Committee on Technology Innovation in Medicine, Institute of Medicine
1 FRONT MATTER; 2 PART I: SETTING THE STAGE; 3 PART II: MANAGING CARE IN THE UNITED STATES; 4 PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA; 5 PART IV: IMPLICATIONS FOR PROVIDERS; 6 PART V: IMPLICATIONS FOR PATIENTS; 7 PART VI: IMPLICATIONS FOR INNOVATORS; 8 PART VII: CONCLUDING OBSERVATIONS; 9 APPENDIXES; 10 INDEX